BioWorld Asia

July 6, 2006

View Archived Issues

Nicotine Receptor Discovery Could Help Treat Addiction

Diatos IPO Would Raise €25M, Sell Quarter Of Firm To Public

No Abstract Read More

Negative European Opinion Given For New Biogeneric

MediGene Shares Slide On FDA PDUFA Date Extension

New Institute Being Built To Focus On Oxford Research

Vectura Gets £45M, Reports Trial Data For Two Products

Cellectis, Bayer CropScience Working On Plant Technology

Other News To Note

Medivir Could Earn $111M Through New Tibotec Deals

Medivir AB could earn about $111 million in up-front and milestone payments from two new drug development licensing deals with Tibotec Pharmaceuticals Ltd. (BioWorld International) Read More

Unable To Attract Funding, TeGenero Going Belly Up

Today's news in brief

BioWorld

BioWorld briefs for June 26, 2026.

Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

ENCALS 2026: From genetics to advancing strategies against ALS

BioWorld Science

Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...

Next wave of BCI firms builds on pioneers to tackle challenges

BioWorld

With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...

Boehringer Ingelheim identifies new mGlu3 receptor agonists

BioWorld Science

Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...

GT-02897 exerts efficacy in preclinical multiple myeloma

BioWorld Science

Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...